Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations

Abdom Radiol (NY). 2018 Jan;43(1):143-148. doi: 10.1007/s00261-017-1251-z.

Abstract

A radiologist issuing a LI-RADS category is, implicitly or explicitly, a member of a multidisciplinary team. If the definite diagnosis of a benign or malignant entity is not possible, categorizing the uncertainty as LR-2, -3, -4, or -M has important management implications. In this article, we discuss the range of options for management or further diagnostic testing and how a LR category may affect the choice between them. We then review recent published data regarding eventual diagnoses following assignment of a LR category.

Keywords: Cirrhosis; Hepatocellular carcinoma; Liver; Management; Multidisciplinary; Standardized reporting.

Publication types

  • Review

MeSH terms

  • Algorithms*
  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / therapy*
  • Contrast Media / administration & dosage*
  • Diagnosis, Differential
  • Humans
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy*
  • Magnetic Resonance Imaging / methods*
  • Neoplasm Staging
  • Tomography, X-Ray Computed / methods*

Substances

  • Contrast Media